Response to letter re: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression

被引：0
|
作者：
Ochi, Nobuaki [1 ]
Ichihara, Eiki [2 ]
Takigawa, Nagio [1 ]
Harada, Daijiro [3 ]
Inoue, Koji [4 ]
Shibayama, Takuo [3 ,5 ]
Hosokawa, Shinobu [6 ]
Kishino, Daizo [7 ]
Harita, Shingo [8 ]
Oda, Naohiro [9 ]
Hara, Naofumi [10 ]
Hotta, Katsuyuki [11 ]
Maeda, Yoshinobu [10 ]
Kiura, Katsuyuki [2 ]
机构：
[1] Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan
[2] Okayama Univ Hosp, Dept Allergy & Resp Med, Okayama, Japan
[3] Natl Hosp Org Shikoku Canc Ctr, Dept Thorac Oncol, Shikoku, Ehime, Japan
[4] Ehime Prefectural Cent Hosp, Dept Resp Med, Matsuyama, Ehime, Japan
[5] Natl Hosp Org Okayama Med Ctr, Dept Resp Med, Okayama, Japan
[6] Japanese Red Cross Okayama Hosp, Dept Resp Med, Okayama, Japan
[7] Himeji Red Cross Hosp, Dept Resp Med, Himeji, Hyogo, Japan
[8] Okayama Saiseikai Gen Hosp, Dept Internal Med, Okayama, Japan
[9] Fukuyama City Hosp, Dept Resp Med, Fukuyama, Hiroshima, Japan
[10] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama, Japan
[11] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 157卷
关键词：
D O I：
10.1016/j.ejca.2021.07.044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：523 / 524
页数：2
相关论文
共 50 条
  • [31] Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
    Papavassiliou, Kostas A. A.
    Marinos, Georgios
    Papavassiliou, Athanasios G. G.
    CELLS, 2023, 12 (06)
  • [32] Predictive effect of PD-L1 expression for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatment for non-small cell lung cancer: A meta-analysis
    Zhang, Binbin
    Liu, Yi
    Zhou, Sijing
    Jiang, Huihui
    Zhu, Ke
    Wang, Ran
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [33] Association Between Efficacy and irAEs in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immune-Checkpoint Inhibitors
    Riudavets, M.
    Mosquera, J.
    Garcia Campelo, R.
    Serra, J.
    Anguera, G.
    Gallardo, P.
    Sullivan, I. G.
    Barba, A.
    Majem, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S446 - S447
  • [34] Efficacy of Immune-Checkpoint Inhibitors and EGFR-TKIs in NSCLC Patients with High PD-L1 Expression
    Masuda, K.
    Horinouchi, H.
    Tanaka, M.
    Higashiyama, R.
    Shinno, Y.
    Sato, J.
    Yoshida, T.
    Matsumoto, Y.
    Goto, Y.
    Kanda, S.
    Yamamoto, N.
    Ohe, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S292 - S293
  • [35] Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer
    Shinkichi Takamori
    Mototsugu Shimokawa
    Takefumi Komiya
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13175 - 13184
  • [36] Impact of the use of antibiotics on the clinical response to immune checkpoint inhibitors in patients with non-small cell lung cancer
    Martinez-Mugica Barbosa, Cristina
    Cercos Lleti, Ana Cristina
    Pampin Sanchez, Ruben
    Duran Roman, Cristina
    Terroba Alonso, Paloma
    Fernandez Gonzalez, Beatriz
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 (06) : 551 - 558
  • [37] Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer
    Takamori, Shinkichi
    Shimokawa, Mototsugu
    Komiya, Takefumi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 13175 - 13184
  • [38] TTFields and Immune-Checkpoint Inhibitor in Metastatic Non-Small Cell Lung Cancer: PD-L1 Subgroups in the Phase 3 LUNAR Study
    Leal, T.
    Kotecha, R.
    Ramlau, R.
    Zhang, L.
    Milanowski, J.
    Cobo, M.
    Roubec, J.
    Petruzelka, L.
    Havel, L.
    Kalmadi, S.
    Ward, J.
    Andric, Z.
    Berghmans, T.
    Gerber, D. E.
    Kloecker, G.
    Panikkar, R.
    Aerts, J.
    Delmonte, A.
    Pless, M.
    Greil, R.
    Rolfo, C.
    Akerley, W.
    Eaton, M.
    Iqbal, M.
    Langer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S96 - S97
  • [39] Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer
    Rossi, Emanuela
    Sgambato, Assunta
    De Chiara, Giovanni
    Casaluce, Francesca
    Losanno, Tania
    Sacco, Paola Claudia
    Santabarbara, Giuseppe
    Gridelli, Cesare
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 419 - 428
  • [40] Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
    Manglaviti, Sara
    Brambilla, Marta
    Signorelli, Diego
    Ferrara, Roberto
    Lo Russo, Giuseppe
    Proto, Claudia
    Galli, Giulia
    De Toma, Alessandro
    Occhipinti, Mario
    Viscardi, Giuseppe
    Beninato, Teresa
    Zattarin, Emma
    Bini, Marta
    Lobefaro, Riccardo
    Massa, Giacomo
    Bottiglieri, Achille
    Apollonio, Giulia
    Sottotetti, Elisa
    Di Mauro, Rosa Maria
    Trevisan, Benedetta
    Ganzinelli, Monica
    Fabbri, Alessandra
    de Braud, Filippo G. M.
    Garassino, Marina Chiara
    Prelaj, Arsela
    CLINICAL LUNG CANCER, 2022, 23 (01) : E17 - E28
12345